# Elvie

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elvie

- Industry: Consumer Products
- Headquarters: London, UK
- Website: www.elvie.com/en-us
- Total disclosed funding: $137M
- Latest round: Series C (Sep 7, 2021)
- Investors on record: 9

## About

Elvie is a pioneering company developing innovative femtech products that enhance women's health, particularly in breastfeeding solutions, aiming to provide convenience and discretion for nursing mothers.Founded in 2013 in London, UK, Elvie specializes in creating advanced breastfeeding solutions for women. The company has accomplished 7 deals, with its most recent funding round being Series C, raising GBP 12.7 mn led by Blume Equity. Founder Tania Boler has an extensive background in health technology, having previously worked with various health initiatives. Elvie's headquarters is in London, and it has made notable advancements in the femtech industry.Elvie offers innovative breastfeeding solutions focused on enhancing mobility and discretion for women. Its flagship products include the Elvie Pump and Elvie Stride, both wearable breast pumps equipped with smart technology. Additionally, Elvie provides the Elvie Trainer, a smart pelvic floor exerciser. These products are tailored for nursing mothers, aiming to ease challenges during breastfeeding, particularly in professional environments, and are available in markets such as the United States, the United Kingdom, Germany, and France.In 2021, Elvie generated revenue of GBP 89.08 mn, with an EBITDA of GBP -28.13 mn. Revenue is driven through direct-to-consumer sales of its product range, including the Elvie Pump and various accessories, which are marketed with promotional offers to enhance customer engagement and loyalty.In March 2025, Elvie was acquired by Willow Innovations, Inc., aiming to integrate its femtech solutions with Willow's medical device technology to enhance maternal health offerings. The company's growth strategy includes launching new products and expanding into additional geographical markets. Funding from the recent acquisition will support these initiatives, further positioning Elvie within the maternal health market.

## Funding rounds

- Series C, Sep 7, 2021, $18M — IPGL, Hiro Capital, Blume Equity, Westerly Winds
- Series C, Jul 26, 2021, $72M — BlackRock Private Equity Partners (PEP), BGF Investment Management, Octopus Investments, Hiro Capital, IPGL, Westerly Winds
- Series B, Mar 29, 2019, $42M — Impact Ventures UK, IPGL, Octopus Investments
- Series A, Nov 25, 2016, $6.2M — Octopus Investments, AllBright.

## Investors

- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A, Series B, Series C
- AllBright. (https://capitalatlas.ai/funds/allbright) — Series A
- Impact Ventures UK (https://capitalatlas.ai/funds/impact-ventures-uk) — Series B
- IPGL — Series B, Series C
- BlackRock Private Equity Partners (PEP) (https://capitalatlas.ai/funds/blackrock-private-equity-partners-pep) — Series C
- BGF Investment Management (https://capitalatlas.ai/funds/bgf-investment-management) — Series C
- Hiro Capital (https://capitalatlas.ai/funds/hiro-capital) — Series C
- Westerly Winds (https://capitalatlas.ai/funds/westerly-winds) — Series C
- Blume Equity (https://capitalatlas.ai/funds/blume-equity) — Series C